CD4 and neoplasm: On the other hand, it has been demonstrated that intratumor MDSCs mainly hamper CD8+ T cell activation, which t suppresses tumor cell escape from the immune system [48, 49]; however, the ability of MDSCs to elicit CD4+ T cell tolerance is still debated and unclear.